Long-term evaluation of lidoflazine in angina pectoris based on exercise tolerance.
D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014992:Xylenes / Q000008:administration & dosage / Q000627:therapeutic use
D000081:Acetamides; D010879:Piperazines; D010919:Placebos; D014665:Vasodilator Agents; D014992:Xylenes